Follow The Filings

BOLD Boundless Bio

Boundless Bio earnings company data as of 6:59 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by BOLD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BOLD insider trades
  • $1.9M bought by 1 insider
  • $134K sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Kevin Tang 10% owner, +1 joint filer
    Buy
    $350K 149,474 shares at $2.34 +5.3% to stake
    Traded Oct 16–20 Filed Oct 20
  2. Kevin Tang 10% owner, +1 joint filer
    Sale
    $54K 18,300 shares at $2.97 0.6% of stake
    Traded Aug 26 Filed Aug 28
  3. Kevin Tang 10% owner, +1 joint filer
    Buy
    $12K 4,863 shares at $2.44 +0.2% to stake
    Traded Jul 17–21 Filed Jul 21
  4. Kevin Tang 10% owner, +1 joint filer
    Buy
    $156K 63,969 shares at $2.43 +2.3% to stake
    Traded Jul 14–16 Filed Jul 16
  5. Kevin Tang 10% owner, +1 joint filer
    Buy
    $222K 91,585 shares at $2.42 +3.4% to stake
    Traded Jul 9–13 Filed Jul 13
  6. Kevin Tang 10% owner, +1 joint filer
    Buy
    $142K 57,210 shares at $2.48 +2.2% to stake
    Traded Jul 6–8 Filed Jul 8
  7. Keith Crandell 10% owner, +4 joint filers
    Sale
    $40K 16,000 shares at $2.49 100% of stake
    Traded Jul 1 Filed Jul 6
  8. Kevin Tang 10% owner, +1 joint filer
    Buy
    $269K 107,463 shares at $2.50 +4.2% to stake
    Traded Jun 30–Jul 2 Filed Jul 2
  9. Kevin Tang 10% owner, +1 joint filer
    Buy
    $715K 286,333 shares at $2.50 +13% to stake
    Traded Jun 25–29 Filed Jun 29

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 1.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G —
10-Q
SCHEDULE 13G —
8-K 1.01,2.05,3.02,5.01,5.02,7.01,8.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
8-K 1.02,2.03
8-K 2.02,5.02,9.01
10-K
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.